Voyager Therapeutics (VYGR) EPS (Basic) (2014 - 2026)
Voyager Therapeutics (VYGR) posted EPS (Basic) of -$0.47 for Q1 2026, little changed sequentially from -$0.47 in Q4 2025, and up 11.68% YoY from -$0.42 in Q1 2025.
Voyager Therapeutics (VYGR) EPS (Basic) (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported EPS (Basic) for 13 years, with the latest figure at -$0.47 in Q1 2026.
- Quarterly EPS (Basic) rose 11.68% year-over-year to -$0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.96 (down 35.06% YoY) and the FY2025 annual result came in at -$2.04, down 80.97% from the prior year.
- EPS (Basic) was little changed at -$0.47 in Q1 2026 per VYGR's latest filing, from -$0.47 in the prior quarter.
- Over five years, EPS (Basic) peaked at $3.05 in Q1 2023 and troughed at -$0.62 in Q4 2022.
- A 5-year average of -$0.09 and a median of -$0.47 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) plunged 506.42% in 2022, then surged 644.86% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.62 in 2022, then surged by 312.82% to $1.31 in 2023, then tumbled by 145.62% to -$0.6 in 2024, then grew by 21.86% to -$0.47 in 2025, then fell by 0.48% to -$0.47 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.47, -$0.47, and -$0.47 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.40 |
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -0.47 |
| Jun 30, 2025 | -0.57 |
| Mar 31, 2025 | -0.53 |
| Dec 31, 2024 | -0.60 |
| Sep 30, 2024 | -0.16 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | 1.31 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | -0.51 |
| Mar 31, 2023 | 3.05 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | -0.50 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | -0.67 |